Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer
- Authors:
- Chih‑Sheng Hung
- Yen‑Chieh Wang
- Jiun‑Wen Guo
- Ruey‑Neng Yang
- Chia‑Long Lee
- Ming‑Hung Shen
- Chi‑Cheng Huang
- Chi‑Jung Huang
- Jhih‑Yun Yang
- Chih‑Yi Liu
-
Affiliations: Department of Internal Medicine, Division of Gastroenterology, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C., Department of Surgery, Division of Urology, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C., Department of Medical Research, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C., Department of Internal Medicine, Sijhih Cathay General Hospital, New Taipei 22174, Taiwan, R.O.C., School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei 24205, Taiwan, R.O.C., Department of Surgery, Taipei‑Veterans General Hospital, Taipei 11217, Taiwan, R.O.C., Department of Mathematics, Taipei Wego Private Senior High School, Taipei 11254, Taiwan, R.O.C., Department of Pathology, Sijhih Cathay General Hospital, New Taipei 22174, Taiwan, R.O.C. - Published online on: December 6, 2019 https://doi.org/10.3892/mmr.2019.10871
- Pages: 659-666
-
Copyright: © Hung et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Keighley MR: Gastrointestinal cancers in europe. Aliment Pharmacol Ther. 18:7–30. 2003. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, et al: Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell. 33:721–735. 2018. View Article : Google Scholar : PubMed/NCBI | |
Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM and Lind GE: The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer. 136:844–853. 2015. View Article : Google Scholar : PubMed/NCBI | |
Moll R, Levy R, Czernobilsky B, Hohlweg-Majert P, Dallenbach-Hellweg G and Franke WW: Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Lab Invest. 49:599–610. 1983.PubMed/NCBI | |
Kim HS, Lee JJ, Do SI, Kim K, Do IG, Kim DH, Chae SW and Sohn JH: Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis. Int J Clin Exp Pathol. 8:5695–5701. 2015.PubMed/NCBI | |
Osborn M, van Lessen G, Weber K, Kloppel G and Altmannsberger M: Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest. 55:497–504. 1986.PubMed/NCBI | |
Tang KD, Kenny L, Perry C, Frazer I and Punyadeera C: The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas. Oncotarget. 8:72272–72280. 2017.PubMed/NCBI | |
Tot T: Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 38:758–763. 2002. View Article : Google Scholar : PubMed/NCBI | |
Fuchs E: Keratins as biochemical markers of epithelial differentiation. Trends Genet. 4:277–281. 1988. View Article : Google Scholar : PubMed/NCBI | |
Lipkin M: Biomarkers of increased susceptibility to gastrointestinal cancer: New application to studies of cancer prevention in human subjects. Cancer Res. 48:235–245. 1988.PubMed/NCBI | |
Mills JC and Sansom OJ: Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract. Sci Signal. 8:re82015. View Article : Google Scholar : PubMed/NCBI | |
Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI | |
Chen T, You Y, Jiang H and Wang ZZ: Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zou XZ, Liu T, Gong ZC, Hu CP and Zhang Z: MicroRNAs-Mediated epithelial-mesenchymal transition in fibrotic diseases. Eur J Pharmacol. 796:190–206. 2017. View Article : Google Scholar : PubMed/NCBI | |
Serrano MJ, Ortega FG, Alvarez-Cubero MJ, Nadal R, Sanchez-Rovira P, Salido M, Rodriguez M, Garcia-Puche JL, Delgado-Rodriguez M, Sole F, et al: EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer. Oncotarget. 5:7486–7497. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T and Roder C: Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients-a prospective study. BMC Cancer. 17:532017. View Article : Google Scholar : PubMed/NCBI | |
Chang WL, Liu YW, Dang YL, Jiang XX, Xu H, Huang X, Wang YL, Wang H, Zhu C, Xue LQ, et al: PLAC8, a new marker for human interstitial extravillous trophoblast cells, promotes their invasion and migration. Development. 145:dev1489322018. View Article : Google Scholar : PubMed/NCBI | |
Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, et al: Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest. 124:2172–2187. 2014. View Article : Google Scholar : PubMed/NCBI | |
Miettinen M: Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial, and merkel cell carcinomas. Mod Pathol. 8:384–388. 1995.PubMed/NCBI | |
Moll R, Divo M and Langbein L: The human keratins: Biology and pathology. Histochem Cell Biol. 129:705–733. 2008. View Article : Google Scholar : PubMed/NCBI | |
Rogulski K, Li Y, Rothermund K, Pu L, Watkins S, Yi F and Prochownik EV: Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene. 24:7524–7541. 2005. View Article : Google Scholar : PubMed/NCBI | |
Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie S, Wang QC, Hu W and Wang L: The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 9:6032018. View Article : Google Scholar : PubMed/NCBI | |
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and Winchester DP: The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin. 67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI | |
Lee CL, Huang CJ, Yang SH, Chang CC, Huang CC, Chien CC and Yang RN: Discovery of genes from feces correlated with colorectal cancer progression. Oncol Lett. 12:3378–3384. 2016. View Article : Google Scholar : PubMed/NCBI | |
Huang CJ, Lee CL, Yang SH, Chien CC, Huang CC, Yang RN and Chang CC: Upregulation of the growth arrest-specific-2 in recurrent colorectal cancers, and its susceptibility to chemotherapy in a model cell system. Biochim Biophys Acta. 1862:1345–1353. 2016. View Article : Google Scholar : PubMed/NCBI | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup J, Kakar S, et al: Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med. 133:1539–1551. 2009.PubMed/NCBI | |
Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousova M, Holubec L and Sturgeon C: Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer. 134:2513–2522. 2014. View Article : Google Scholar : PubMed/NCBI | |
Dolscheid-Pommerich RC, Manekeller S, Walgenbach- Brunagel G, Kalff JC, Hartmann G, Wagner BS and Holdenrieder S: Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in gastrointestinal cancer using LOCI-based assays. Anticancer Res. 37:353–359. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kumar Y, Tapuria N, Kirmani N and Davidson BR: Tumour M2-pyruvate kinase: A gastrointestinal cancer marker. Eur J Gastroenterol Hepatol. 19:265–276. 2007. View Article : Google Scholar : PubMed/NCBI | |
Myllykangas S, Bohling T and Knuutila S: Specificity, selection and significance of gene amplifications in cancer. Semin Cancer Biol. 17:42–55. 2007. View Article : Google Scholar : PubMed/NCBI | |
Myllykangas S, Himberg J, Bohling T, Nagy B, Hollmen J and Knuutila S: DNA copy number amplification profiling of human neoplasms. Oncogene. 25:7324–7332. 2006. View Article : Google Scholar : PubMed/NCBI | |
Lukyanchuk VV, Friess H, Kleeff J, Osinsky SP, Ayuni E, Candinas D and Roggo A: Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers. Anticancer Res. 23:2711–2716. 2003.PubMed/NCBI | |
Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgo E, Rajendran PS, Miranda SP, et al: CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N Engl J Med. 374:211–222. 2016. View Article : Google Scholar : PubMed/NCBI | |
Pilati C, Taieb J, Balogoun R, Marisa L, de Reynies A and Laurent-Puig P: CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification. Ann Oncol. 28:1032–1035. 2017. View Article : Google Scholar : PubMed/NCBI | |
Singh R, Kapur N, Mir H, Singh N, Lillard JW Jr and Singh S: CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and alphavbeta3 integrin clustering. Oncotarget. 7:7343–7353. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wu K, Zhang X, Li F, Xiao D, Hou Y, Zhu S, Liu D, Ye X, Ye M, Yang J, et al: Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas. Nat Commun. 6:101312015. View Article : Google Scholar : PubMed/NCBI | |
Chen NP, Uddin B, Voit R and Schiebel E: Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci USA. 113:990–995. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhou H, Zhang Y, Chen Q and Lin Y: AKT and JNK signaling pathways increase the metastatic potential of colorectal cancer cells by altering transgelin expression. Dig Dis Sci. 61:1091–1097. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mills KM, Brocardo MG and Henderson BR: APC binds the Miro/Milton motor complex to stimulate transport of mitochondria to the plasma membrane. Mol Biol Cell. 27:466–482. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ivanovska J, Zlobec I, Forster S, Karamitopoulou E, Dawson H, Koelzer VH, Agaimy A, Garreis F, Soder S, Laqua W, et al: DAPK loss in colon cancer tumor buds: Implications for migration capacity of disseminating tumor cells. Oncotarget. 6:36774–36788. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zeng Y, Xie H, Qiao Y, Wang J, Zhu X, He G, Li Y, Ren X, Wang F, Liang L and Ding Y: Formin-Like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer. Cancer Sci. 106:1385–1393. 2015. View Article : Google Scholar : PubMed/NCBI | |
Asfaha S, Hayakawa Y, Muley A, Stokes S, Graham TA, Ericksen RE, Westphalen CB, von Burstin J, Mastracci TL, Worthley DL, et al: Krt19(+)/Lgr5(−) cells are radioresistant cancer-initiating stem cells in the colon and intestine. Cell Stem Cell. 16:627–638. 2015. View Article : Google Scholar : PubMed/NCBI | |
Li WX, Xiao HW, Hong XQ and Niu WX: Predictive value of CK20 in evaluating the efficacy of treatment and prognosis after surgery for colorectal cancer. Genet Mol Res. 14:5823–5829. 2015. View Article : Google Scholar : PubMed/NCBI | |
Saad RS, Ismiil N, Dube V, Nofech-Mozes S and Khalifa MA: CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma. Am J Clin Pathol. 132:531–538. 2009. View Article : Google Scholar : PubMed/NCBI | |
Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, Melchior A, Heynemann H, Fornara P and Taubert H: Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev. 18:2190–2194. 2009. View Article : Google Scholar : PubMed/NCBI | |
Mizuuchi E, Semba S, Kodama Y and Yokozaki H: Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer. 124:1802–1810. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ding SJ, Li Y, Tan YX, Jiang MR, Tian B, Liu YK, Shao XX, Ye SL, Wu JR, Zeng R, et al: From proteomic analysis to clinical significance: Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics. 3:73–81. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hammoudi A, Song F, Reed KR, Jenkins RE, Meniel VS, Watson AJ, Pritchard DM, Clarke AR and Jenkins JR: Proteomic profiling of a mouse model of acute intestinal apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochem Biophys Res Commun. 440:364–370. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yang SH, Huang CJ, Lee CL, Liu CC, Chien CC and Chen SH: Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer. Hepatogastroenterology. 57:710–715. 2010.PubMed/NCBI | |
Yang RN, Yang SH, Chang CC, Chien CC, Pan S and Huang CJ: Upregulation of fecal cytokeratin 19 is associated with prognosis in older colorectal cancer patients. Genet Test Mol Biomarkers. 14:703–708. 2010. View Article : Google Scholar : PubMed/NCBI | |
Chang CC, Yang SH, Chien CC, Chen SH, Pan S, Lee CL, Lin CM, Sun HL, Huang CC, Wu YY, et al: Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. BMC Cancer. 9:3762009. View Article : Google Scholar : PubMed/NCBI | |
Kende AI, Carr NJ and Sobin LH: Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology. 42:137–140. 2003. View Article : Google Scholar : PubMed/NCBI | |
Samija I, Lukac J, Mubrin MK, Kirac I, Kovacevic D and Kusic Z: Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR. Int J Biol Markers. 28:174–181. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kojima S, Sakamoto T, Nagai Y, Honda M and Ogawa F: Metachronous rectal metastasis from primary transverse colon cancer: A case report. Surg Case Rep. 4:902018. View Article : Google Scholar : PubMed/NCBI | |
Reisher SR, Hughes TE, Ordovas JM, Schaefer EJ and Feinstein SI: Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2. Proc Natl Acad Sci USA. 90:5757–5761. 1993. View Article : Google Scholar : PubMed/NCBI | |
Ferruzza S, Rossi C, Scarino ML and Sambuy Y: A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium. Toxicol In Vitro. 26:1252–1255. 2012. View Article : Google Scholar : PubMed/NCBI | |
Meunier V, Bourrie M, Berger Y and Fabre G: The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol. 11:187–194. 1995. View Article : Google Scholar : PubMed/NCBI | |
Buhrke T, Lengler I and Lampen A: Analysis of proteomic changes induced upon cellular differentiation of the human intestinal cell line Caco-2. Dev Growth Differ. 53:411–426. 2011. View Article : Google Scholar : PubMed/NCBI | |
Allegra C and Sargent D: Molecular diagnostics: Assays, tissues, progress, and pitfalls. J Clin Oncol. 21:395–396. 2003. View Article : Google Scholar : PubMed/NCBI | |
Bustin SA and Dorudi S: Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev Mol Diagn. 4:599–607. 2004. View Article : Google Scholar : PubMed/NCBI | |
Bardelli A and Velculescu VE: Mutational analysis of gene families in human cancer. Curr Opin Genet Dev. 15:5–12. 2005. View Article : Google Scholar : PubMed/NCBI | |
Rozen P: Cancer of the gastrointestinal tract: Early detection or early prevention? Eur J Cancer Prev. 13:71–75. 2004. View Article : Google Scholar : PubMed/NCBI | |
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI | |
Center MM, Jemal A, Smith RA and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin. 59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI | |
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 372:2509–2520. 2015. View Article : Google Scholar : PubMed/NCBI | |
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 351:337–345. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 350:2335–2342. 2004. View Article : Google Scholar : PubMed/NCBI | |
Imai Y, Yamagishi H, Fukuda K, Okamura T, Ono Y, Ban S, Inoue T and Ueda Y: Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma. Anticancer Res. 34:159–167. 2014.PubMed/NCBI | |
Barr T, Sureshchandra S, Ruegger P, Zhang J, Ma W, Borneman J, Grant K and Messaoudi I: Concurrent gut transcriptome and microbiota profiling following chronic ethanol consumption in nonhuman primates. Gut Microbes. 9:338–356. 2018.PubMed/NCBI | |
Turroni S, Vitali B, Candela M, Gionchetti P, Rizzello F, Campieri M and Brigidi P: Antibiotics and probiotics in chronic pouchitis: A comparative proteomic approach. World J Gastroenterol. 16:30–41. 2010.PubMed/NCBI | |
Singh A, Trivedi P and Jain NK: Advances in siRNA delivery in cancer therapy. Artif Cells Nanomed Biotechnol. 46:274–283. 2018. View Article : Google Scholar : PubMed/NCBI | |
Das M, Musetti S and Huang L: RNA interference-based cancer drugs: The roadblocks, and the ‘Delivery’ of the promise. Nucleic Acid Ther. 29:61–66. 2019. View Article : Google Scholar : PubMed/NCBI | |
Zheng M, Tao W, Zou Y, Farokhzad OC and Shi B: Nanotechnology-based strategies for siRNA brain delivery for disease therapy. Trends Biotechnol. 36:562–575. 2018. View Article : Google Scholar : PubMed/NCBI | |
Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A and Bukholm G: Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol. 29:862–866. 2003. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Hu Q, Li G, Li L, Liang S, Zhang Y, Liu J, Fan Z, Li L, Zhou B, et al: ONZIN upregulation by mutant p53 contributes to osteosarcoma metastasis through the CXCL5-MAPK signaling pathway. Cell Physiol Biochem. 48:1099–1111. 2018. View Article : Google Scholar : PubMed/NCBI |